OpenRx Open Medications Explorer
© 2026 OpenRx · public-domain U.S. government data
On this page

Regranex

becaplermin

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Regranex
Proper name
becaplermin
Licence type
351(a)
BLA number
103691
Applicant
Lynch Regenerative Medicine, LLC
Center
CDER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
0.0001 Gel Topical Tube Rx December 16, 1997

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity